Share Capital | Note 7. Share Capital Preferred Stock The Company’s authorized capital includes 50,000,000 shares of preferred stock of $0.0001 par value. The designation of rights including voting powers, preferences, and restrictions shall be determined by the Board of Directors before the issuance of any shares. During the nine months ended September 30, 2017, pursuant to an agreement between the Company and the holders of the Series A preferred stock, the stock was re-designated as Series A-1 Preferred Stock, outstanding shares increased to 555,555 shares with a redemption price of $1.80, dividends of 10% per annum and the redemption date extended to February 1, 2018. Common Stock The Company is authorized to issue 33.3 million shares of common stock, par value of $0.0001, after giving effect to the, one new share for every six old shares, reverse stock split which was approved by the stock holders on April 19, 2017. During the nine months ended September 30, 2017 the Company: ● Issued 91,667 shares of common stock for services provided with a fair value of $176,055. ● Issued 127,366 shares of common stock for exercise of warrants at a price of $0.80 per share ● Issued 417,461 shares of common stock for cash proceeds of $265,000 ● Issued 859,802 shares of common stock for settlement of related party loan in the amount of $662,048 ● Issued 3,000,000 shares of common stock for employment commencement of 5 year employment contracts for executives with a fair value of $2,750,000. ● Issued 55,556 shares of common stock for exercise of warrants at a price of $0.80 per shares ● Issued 37,500 shares of common stock for settlement of amount owing of $30,000 Stock Purchase Warrants At September 30, 2017, the Company had reserved 578,014 shares of its common stock for the outstanding warrants with weighted average exercise price of $17.98. Such warrants expire at various times up to December 2019 and had no intrinsic value as at September 30, 2017. During the nine months ended September 30, 2017, 238,095 warrants were forfeited, 349,095 warrants were issued, for services performed and valued under the Black-Scholes valuation method, and 182,922 warrants were exercised. The assumptions used in calculating the fair value under the Black-Scholes option valuation model for warrants issued by the Company during the nine months ended September 30, 2017: Common stock fair value $ 1.92 Risk-free interest rate 2.5 % Expected dividend yield 0 % Expected warrant life (years) 0.5 Expected stock volatility 107 % Stock compensation The shareholders approved a stock option plan on August 6, 2013, the 2013 Equity Incentive Plan (“2013 Plan”). The 2013 Plan is for the issuance of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalents, cash bonuses and other stock-based awards to employees, directors and consultants of the Company. There have been no options issued in the nine months ended September 30, 2017. A summary of the 2013 Plan options for the nine months ended September 30, 2017, is as follows: Number of Weighted Average Options Exercise Price Outstanding at January 1, 2017 141,250 $ 14.83 Forfeited (32,200 ) 22.61 Outstanding at September 30, 2017 109,050 18.71 As at September 30, 2017 there was unrecognized compensation expense of approximately $86,000 to be recognized over the remaining vesting periods. At September 30, 2017, 109,050 shares of common stock were reserved for all outstanding options and future commitments under the 2013 Equity Incentive Plan. Prior to the 2013 Plan the Company issued stock options to employees. A summary of the Company’s other stock options for the nine months ended September 30, 2017, is as follows: Number of Weighted Average Options Exercise Price Outstanding at January 1, 2017 and September 30, 2017 145,950 $ 3.18 |